The 36-month survival rate of only 67.57% for patients with low Klotho levels suggests that these individuals may be at increased risk for adverse events, potentially due to underlying pathological processes such as vascular calcification and inflammation, which are often exacerbated in CKD [2,35]. This evidence concerns the gene KL and chronic kidney disease.